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significantly weaker than that of community controls. Table 1
presents further details.
Conclusions These results indicate that SAM may be associated
with a number of adverse long-term effects, including stunting,
abnormal body composition and functional impairment. It will
be crucial to identify effective strategies, not only to prevent
SAM in the first place, but to improve long-term outcomes in
SAM survivors. Interventions might include more proactive case
finding to encourage earlier detection and continued follow-up
after the initial treatment to support high risk children and
families.
Abstract P05 Table 1 Linear regression of cases vs community
controls
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Aims Health is a key factor in enabling universal access to edu-
cation. Children miss over 200 million days of school every year
due to illness. Traditionally, vertical approaches have been used
to individually tackle child health and nutrition problems such as
malnutrition or malaria. However, these interventions overlook
the complex interactions between them. We therefore sought to
develop a comprehensive, integrated school health and nutrition
programme to produce long-term and sustainable improvements
to child health and education outcomes.
Methods A 3 year pilot study was carried out in a population of
2,000 children aged 5–16 in rural Western Kenya. The pro-
gramme comprised school meals, vitamin A supplementation,
insecticide-treated bed nets, deworming, hand washing and
health education. Data were collected on programme delivery
and on health, nutrition and education parameters.
Results 2103 children were dewormed using Albendazole,
supplied with insecticide-treated bed nets and Vitamin A was
given to all children under 5. School meals were provided daily
to all children. Additional water points with soap were installed
with a 32.5% observational increase in clean hands and 86%
increased soap use. Preliminary results show increased school
enrolment and reductions in school absenteeism (OR 0.70, 95%
CI 0.61–0.82, p= < 0.001), in anaemia (OR 0.25, 95%
CI 0.16–0.40, p= < 0.001) and undernutrition, both stunting
(OR 0.56, 95% CI 0.48–0.65, p= < 0.001) and underweight
(OR 0.55, 95% CI 0.42–0.73, p = 0.001).
Conclusion Our experience shows that a comprehensive school
health and nutrition programme is feasible and that monitoring
for health and education outcomes is possible in this context.
The data suggest improvements in childhood anaemia and nutri-
tion in conjunction with improved school attendance and enrol-
ment. Complex interventions for improving school health are
feasible and can produce long-term benefits above and beyond
vertical programme initiatives.
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Aims Challenges in seeking parents’ consent for research at the
point when their child is critically ill have been a significant bar-
rier to improving treatments for children and conducting trials.
In 2008 UK legislation was amended to enable consent for emer-
gency research to be sought after a child has been given the
investigational drug or device. This is known as deferred con-
sent. CONNECT is the first UK study to explore parent and
practitioner views and experiences of deferred consent in child-
ren’s clinical care trials. It aimed to integrate evidence and ethi-
cal theory to inform practice guidelines to optimise recruitment
and consent in this challenging setting.
Methods Mixed methods qualitative and quantitative study with
354 participants (292 parents, 39 nurses, 19 doctors and 4 Clini-
cal Trials Unit practitioners). We integrated findings with pre-
vious research and ethical theory to develop draft guidance on
deferred consent. The CONNECT advisory group and 32 key
stakeholders (critical care practitioners, ethicists and parents)
contributed to the development of the final CONNECT
guidance.
Results Parents may be initially shocked or angered to discover
their child can be entered into a trial without their prior con-
sent. However practitioner explanations of why consent is
deferred can help address parents’ initial concerns and reassure
them. Parents view deferred consent as more acceptable for trials
of medical interventions already used in clinical practice than tri-
als involving new interventions or a change in clinical practice.
Practitioners experienced in deferred consent describe how fami-
lies are receptive to the consent method, if conducted sensitively
and if the timing is appropriate. CONNECT guidance provides
recommendations to inform: 1) pre-trial research for potentially
challenging trials; 2) publicising trials that use deferred consent;
3) seeking deferred consent; 4) seeking deferred consent when a
child has died; 5) written trial information; and 6) child assent.
Conclusion Those involved in the funding, design, conduct and
ethical review of critical care trials can use CONNECT guidance
to help ensure approaches to deferred consent are appropriate
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to the needs of children and their parents. Further research is
required to explore the views of children and bereaved parents
who have experienced deferred consent.
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Aims To estimate background trends in intussusception admis-
sions prior to the introduction of rotavirus vaccine in the UK.
To compare the quality of Hospital Episode Statistics (HES) with
intussusception data from the British Paediatric Surveillance Unit
(BPSU).
Methods Retrospective analysis of the NHS inpatient HES was
carried out to estimate background intussusception trends in the
paediatric population in England from 1995 to 2009. Data link-
age was performed between HES and previously obtained BPSU
data on intussusception among infants from March 2008 to
March 2009.
The ICD-10 intussusception codes (K56.1, K38.8) were used
to identify cases in HES (1995–2009). Incidence trends were cal-
culated using the Office for National Statistics live births and
mid-year population estimates as denominator.
We performed probabilistic data linkage to match HES
records with BPSU cases, followed by a manual review to
confirm the status of matched (and possibly matched) pairs
(2008–2009). Capture-recapture methods allowed assessing the
accuracy of HES and completeness of both data sources for
intussusception. Validated incidence rates in infants were
obtained following data linkage.
Results Of 11,259 intussusception records identified in HES and
after excluding 2538 (22.5%) duplicates, 8721 (77.5%) cases
were retained for trends analysis. A significant decline in back-
ground trends was observed predominantly among infants from
86.0/100,000 in 1997 to 34.0/100,000 in 2009 (60% reduction,
p = 0.001). Seasonal modelling showed a significant excess of
intussusception cases in winter and spring during 1995–2009
(p = 0.001, n = 4957 infants).
Data linkage between 254 intussusception cases in HES and
190 cases previously obtained via the BPSU (2008–2009)
resulted in 163 matched pairs. Completeness of reporting was
85.8% for HES (163/190 BPSU cases) compared to 81.5% for
BPSU (163/200 HES cases). The positive predictive value of
HES was 78.7% (200/254 confirmed cases). The Lincoln-
Petersen estimate yielded a total of 233 intussusception cases
(95% CI: 227.4 to 238.8). The estimated annual incidence
of intussusception among infants in England increased
from 24.2/100,000 (unvalidated) to 28.9/100,000 (validated)
(2008–2009).
Conclusions Background intussusception trends have declined
among infants in England. The high accuracy and completeness
of HES for intussusception highlight the usefulness of routinely
collected data in monitoring rotavirus vaccine safety in England.
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Introduction Primary congenital hypothyroidism (CHT) is due
to reduced thyroid hormone production. Oral thyroxine therapy
commenced soon after birth improves cognitive development
and growth. Despite 30 years of newborn screening for CHT in
the UK, its success in identifying babies who require lifelong
therapy for CHT remains unclear.
Aim To determine, through UK-wide active surveillance, the
number and characteristics of children aged £5 years diagnosed
annually with CHT, detected by screening or after clinical mani-
festations, and to describe clinical management.
Results During 13 months of surveillance, 704 children with
positive screening results were reported by screening laborato-
ries. Local clinicians completed 643 questionnaires (response
rate = 91%). An additional 20 children aged <5 years were
notified who were not identified through screening, including
three diagnosed prior to screening (2 family history, 1 unwell)
and 17 with negative screening tests (10 preterm, 5 unwell,
2 Downs syndrome); screening results were untraceable for
2 children. Of 643 screen positive children, 260 (40%) were
boys, 130 (20%) were <37 weeks gestation and most were of
white or Asian ethnicity (379[59%] and 133[21%] respectively).
Investigations carried out soon after referral demonstrated
serum TSH >40 mU/l in 365; in an additional 43 children an
abnormal thyroid scan result was associated with serum TSH
£40 mU/l. Based on the reported initial investigations for 643
children, an expert panel assigned a diagnosis of CHT in 410,
excluded CHT in 120 and considered 113 had probable/possible
CHT requiring follow-up. The local clinicians commenced 485
children on oral thyroxine, 401 of whom were assigned as hav-
ing definite CHT by the expert panel. During 12 months of fol-
low up after diagnosis, eleven children died of causes unrelated
to CHT.
Conclusion Our findings suggest that the predictive value of a
positive screening test is at most 81% (523/643) assuming CHT
is confirmed in those with possible CHT as an initial diagnosis.
Our data suggest that permanent CHT cannot be confirmed at
initial diagnostic investigation in a significant proportion of
screen positive babies. Follow up of this cohort is continuing to
determine outcome by two years of age.
Funding Public Health England (NHS Newborn Blood Spot
Screening Programme).
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